sodium valproate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
EPILIM sodium valproate 100mg crushable tablet blister pack
AUST R: 15373
Active ingredients:
sodium valproate

Dosage form:
Tablet, uncoated

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

Deletion from market:
30 Sep 2026

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
There is a current shortage with limited availability until 15 April 2026. An overseas-registered product has been approved for supply under section 19A. The approval holder, Sanofi Aventis, can be contacted for details on supply on 1800 818 806. Supply is expected to return to normal after 15 April 2026 and continue until the medicine is deleted from the market on 30 September 2026